762 related articles for article (PubMed ID: 25450382)
1. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
2. Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder.
Liu X; Zhang L; Cheng K; Wang X; Ren G; Xie P
J Affect Disord; 2014 Jul; 163():133-9. PubMed ID: 24479999
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients.
Zheng G; Wang H; Zhang X; Yang Y; Wang L; Du L; Li W; Li J; Qu A; Liu Y; Wang C
PLoS One; 2013; 8(12):e83025. PubMed ID: 24349425
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
6. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
Appaiah HN; Goswami CP; Mina LA; Badve S; Sledge GW; Liu Y; Nakshatri H
Breast Cancer Res; 2011 Sep; 13(5):R86. PubMed ID: 21914171
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
9. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-34a levels are reduced in colorectal cancer.
Nugent M; Miller N; Kerin MJ
J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208
[TBL] [Abstract][Full Text] [Related]
11. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification.
Lou G; Ma N; Xu Y; Jiang L; Yang J; Wang C; Jiao Y; Gao X
Int J Mol Med; 2015 Nov; 36(5):1400-8. PubMed ID: 26352225
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
14. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
[TBL] [Abstract][Full Text] [Related]
15. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
16. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
[TBL] [Abstract][Full Text] [Related]
17. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma.
Alegre E; Sanmamed MF; Rodriguez C; Carranza O; Martín-Algarra S; González A
Arch Pathol Lab Med; 2014 Jun; 138(6):828-32. PubMed ID: 24878024
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
